Anti-glomerular basement membrane disease: variant forms and underlying mechanisms

Area of Science:

• Nephrology
• Immunology
• Autoimmune Diseases

Background:

• Anti-glomerular basement membrane (GBM) disease is a severe autoimmune glomerulonephritis.
• Pathogenic anti-GBM antibodies target kidney and alveolar basement membranes, causing crescent formation and potential lung hemorrhage.
• Despite improved patient survival with current treatments, kidney survival remains poor due to delayed diagnosis and treatment initiation.

Purpose of the Study:

• To categorize and review recognized variant forms of anti-GBM disease.
• To discuss the immunological properties, clinical presentations, and underlying mechanisms of these variants.
• To highlight how understanding these variants can inform personalized therapeutic strategies.

Main Methods:

• Literature review and synthesis of existing research on anti-GBM disease variants.
• Classification of variant forms based on immunological and clinical characteristics.
• Discussion of phenotypic features, pathological findings, and prognostic differences compared to classical anti-GBM disease.

Main Results:

• Four categories of anti-GBM disease variants are proposed: overlapping autoimmune syndromes, immunological distinct forms, clinical phenotypic variants, and medication-associated forms.
• These variants exhibit distinct clinical manifestations, pathological findings, and prognoses compared to classical anti-GBM disease.
• Specific variants include those overlapping with ANCA, membranous nephropathy, IgA nephropathy, Alport syndrome, seronegative disease, recurrent disease, elderly patients, normal kidney function, and medication-associated cases.

Conclusions:

• Recognizing and understanding the heterogeneity of anti-GBM disease variants is crucial.
• These variants present unique challenges and require tailored approaches.
• Further insights into the pathophysiology of these variants can facilitate the development of personalized therapies for improved patient outcomes.